Latest news with #U.S.TradeCommission
NBC News
06-07-2025
- Business
- NBC News
From lumber to lighting: How Trump's tariffs drive up home construction costs
NBC News modeled out a 3-bedroom home and found tariffs added more than $4,000 to total costs. By Alex Ford and Jiachuan Wu July 6, 2025 Lumber from Canada? That will be another $534. Major appliances from China? Add a cool $445. New homes in the United States are set to get more expensive thanks to President Donald Trump's tariff agenda, which is expected to raise the costs of a wide variety of materials that go into building houses. An NBC News analysis of building materials and import data found that the total cost of building a mid-range single-family home could rise by more than $4,000 — an estimate that industry experts who reviewed the analysis called conservative. An April survey from the National Association of Home Builders estimated tariff impacts at $10,900 per home. Neither analysis included labor costs. Robert Dietz, chief economist at the National Association of Home Builders, said the tariffs have an impact beyond their direct cost as they send uncertainty rippling through the supply chain and leave builders unsure how to plan for the future. "About three-quarters of home builders right now are having difficulty pricing their homes for buyers because of uncertainty due to construction input costs," Dietz said. The United States remains in a housing shortage that has driven up costs. The NBC News Home Buyer Index, which measures how difficult a local housing market is, has remained at an extreme difficulty level for more than two years. And conversations about how to encourage building more housing has become a major part of U.S. political discussions, especially among some Democrats. Trump, meanwhile, has continued to pursue an aggressive tariff agenda while promising that the United States would sign trade deals, most of which have yet to materialize. Whether tariffs are implemented, paused or reversed, the timeline for cost impacts will vary significantly across suppliers, materials and regions. Dietz said that while some suppliers may initially absorb parts of tariff costs, "generally speaking, in the long run, you would expect consumers to pay most of the tariff." NBC News modeled the cost of materials for an 1,800 square-foot single-family house and then analyzed import and survey data from the U.S. Trade Commission and the Census Bureau's annual manufacturing survey to determine which countries dominate the home construction supply chain. While some foundational materials like concrete are sourced domestically, others — such as electrical equipment, lighting and fixtures — depend heavily on imports. Products from China, Mexico and Canada — countries that are currently tariffed at high rates — are responsible for the largest projected cost increases in our model home. We reached this by calculating a weighted tariff rate for each item based on the share of imports from each country and the tariff rate for that country, with the assumption that the full cost of each tariff was passed on to the consumer. Materials primarily imported from China would add $1,708 to per-home costs, Canadian products would contribute $1,300, and Mexican imports would add $981. Take lumber, for example. NBC News calculated that a typical 1,800-square-foot home requires about 14,400 board feet of framing lumber, totaling roughly $7,762 at wholesale prices. Almost one-third of the U.S. lumber supply is imported, and Canada supplied nearly 80% of the United States' $14.5 billion in annual imports in 2021. A weighted 23% tariff could increase lumber prices by 7% — adding roughly $534 to home framing costs alone. Scroll down to see how tariffs could raise prices during each phase of construction. Model of home NBC News designed a single-family house model structure for our analysis. Our model is: 1,800 square foot Three bedrooms Two bathrooms A combined living room and kitchen A laundry room Foundation and framing The backbone of U.S. homes is largely dependent on major trading partners that have faced some of Trump's most aggressive tariffs. Canada supplies the majority of U.S. imported material in the first phase of construction, including 24% of framing lumber. Rebar, the long steel bars that help reinforce concrete, faces a 5% price increase thanks to its Canadian and Mexican origins. And there are plenty of smaller pieces crucial to home building, such as anchor bolts and framing nails: Taiwan provides 19% of those, which will cost 8% more. Building envelope Many of the materials necessary to seal a home's exterior from water and weather face similarly steep tariffs. Costs for windows and exterior doors from Canada, which supply 2% of U.S. homes, are expected to rise by just 1%. And 20% of door locks and viewers come from China, which will mean a 10% jump. Others face smaller increases. Utilities Mexico and China split supply across key categories in the electrical phase: switches/outlets increase 14%, wiring rises 13%, and safety devices increase 11%. Service panels and breakers rise 11%, with 22% of supply from Mexico. The plumbing system is dominated by Chinese imports, with 4% increases for lines/fittings, 13% increases for toilets and bathroom sinks, and a 9% increase for water heaters. To regulate indoor temperature, the HVAC system includes a combined heating and cooling unit and ductwork — both sourced primarily from Mexico with a 6% increase — along with a thermostat, up 8%. Interior finishes Window blinds increase 12%, with 15% of supply sourced from China (32%). Stone countertops face 8% increases, sourced equally from India and Brazil (8% each). Lighting fixtures and tile both increase 7%. Lighting is dominated by Chinese imports, while tile comes primarily from Italy (9%) and Spain (7%). Exterior finishes The build completes with exterior details and landscaping. China supplies the majority of higher-impact items: house numbers (9% increase), exterior lighting (7% increase), and mulch 6% increase). Landscaping materials experience minimal 1% increases, with Canada providing 3% of U.S. imports. Altogether, the impact of tariffs across the homebuilding process adds $4,405 to the materials cost — raising the total cost of materials from $86,516 to $90,921 for a typical 1,800-square-foot home. Methodology As the basis for the analysis, NBC News designed a typical 1,800-square-foot single-family home, cataloged all required construction materials, calculated precise quantities using industry standards and collected current market prices primarily from national vendors. Each material was mapped to its corresponding North American Industry Classification System code to align with the official U.S. Census Bureau trade data. NBC News calculated import dependency as total imports for a given item category divided by its total domestic supply, using data from the U.S. Trade Commission and the Annual Survey of Manufactures. For each material category, we calculated a weighted average tariff rate based on the amount the United States imports from each tariffed country, then estimated total price impacts by multiplying import dependency by the weighted tariff rate. This analysis provides a snapshot of potential cost impacts using national averages and simplified assumptions, but it does not account for long-term market adjustments, regional variations, supply chain adaptations or uneven cost absorption across the supply chain.
Yahoo
09-02-2025
- Business
- Yahoo
China makes some of Americans' most common medicines. They won't be spared from Trump's tariffs
President Donald Trump's broad 10 percent tariff on China could drive up the cost, or cause shortages, of popular generic medicines such as antibiotics or cancer treatment drugs for consumers in the United States, experts have warned. Ordinary painkillers, psychoactive medications, blood thinners, heart medications, antihistamines, antibiotics and diuretics are just some of the essential medications that the U.S. relies on China to manufacture. In 2023, the U.S. spent more than $2.02 billion on these kinds of imports from China alone, according to the U.S. Trade Commission. Trump's additional 10 percent tax on Chinese imports, without an exemption for this, could disrupt the pharmaceutical and medical supply chain, which could lead to shortages or force companies to increase the cost of generic drugs to consumers. In a letter to Trump, the American Hospital Association pleaded with the president to exempt medical equipment and pharmaceuticals from his tariffs, saying the possibility of shortages could put patients 'at significant risk of harm, including death.' 'Tariffs, as well as any reaction of the countries on whom such tariffs are imposed, could reduce the availability of these life-saving medications and supplies in the U.S,' the group wrote. 'For example, U.S. providers import many cancer and cardiovascular medications, immunosuppressives, antibiotics and combination antibiotics from China.' 'Generic manufacturers simply can't absorb new costs,' John Murphy III, the president and CEO of the Association for Accessible Medicines said in a statement. 'Our manufacturers sell at an extremely low price, sometimes at a loss, and are increasingly forced to exit markets where they are underwater. The overall value of all generic sales in the U.S. has gone down by $6.4 billion in five years despite growth in volume and new generic launches. Tariffs would make this much worse,' Murphy said. China supplies the U.S. with approximately 30 percent of its active pharmaceutical ingredients, the raw ingredients found in medicines that make them function, according to the American Hospital Association. China also is one of the U.S.'s main source of medical equipment and devices such as single-use blood pressure cuffs, stethoscope covers, anesthesia instruments and more. Nearly one-third of disposable face masks and almost all plastic gloves come from China. 'For many patients, even a temporary disruption in their access to these needed medications could put them at significant risk of harm, including death. Carefully planned chemotherapy treatments and antibiotic schedules are essential to giving patients the best chance of overcoming their disease. Similarly, the provision of necessary cardiovascular medications must be continuous to preserve their cardiovascular health,' the American Hospital Association said. For the last 10 years, the U.S. has become increasingly reliant on foreign countries for pharmaceuticals or medical equipment because it is less expensive to manufacture overseas. Though tariffs may incentivize the U.S. to begin manufacturing its own drugs, it will not happen overnight and as a result, shortages can occur. But the long-term effects of the tariffs – whether that's shortages or increased drug costs – will not be tangible for several months, Dr. Aaron Kesselheim, a professor of medicine at Harvard Medical School whose research focuses on prescription drugs, told NBC News.
Yahoo
08-02-2025
- Business
- Yahoo
China makes some of Americans' most common medicines. They won't be spared from Trump's tariffs
President Donald Trump's broad 10 percent tariff on China could drive up the cost, or cause shortages, of popular generic medicines such as antibiotics or cancer treatment drugs for consumers in the United States, experts have warned. Ordinary painkillers, psychoactive medications, blood thinners, heart medications, antihistamines, antibiotics and diuretics are just some of the essential medications that the U.S. relies on China to manufacture. In 2023, the U.S. spent more than $2.02 billion on these kinds of imports from China alone, according to the U.S. Trade Commission. Trump's additional 10 percent tax on Chinese imports, without an exemption for this, could disrupt the pharmaceutical and medical supply chain, which could lead to shortages or force companies to increase the cost of generic drugs to consumers. In a letter to Trump, the American Hospital Association pleaded with the president to exempt medical equipment and pharmaceuticals from his tariffs, saying the possibility of shortages could put patients 'at significant risk of harm, including death.' 'Tariffs, as well as any reaction of the countries on whom such tariffs are imposed, could reduce the availability of these life-saving medications and supplies in the U.S,' the group wrote. 'For example, U.S. providers import many cancer and cardiovascular medications, immunosuppressives, antibiotics and combination antibiotics from China.' 'Generic manufacturers simply can't absorb new costs,' John Murphy III, the president and CEO of the Association for Accessible Medicines said in a statement. 'Our manufacturers sell at an extremely low price, sometimes at a loss, and are increasingly forced to exit markets where they are underwater. The overall value of all generic sales in the U.S. has gone down by $6.4 billion in five years despite growth in volume and new generic launches. Tariffs would make this much worse,' Murphy said. China supplies the U.S. with approximately 30 percent of its active pharmaceutical ingredients, the raw ingredients found in medicines that make them function, according to the American Hospital Association. China also is one of the U.S.'s main source of medical equipment and devices such as single-use blood pressure cuffs, stethoscope covers, anesthesia instruments and more. Nearly one-third of disposable face masks and almost all plastic gloves come from China. 'For many patients, even a temporary disruption in their access to these needed medications could put them at significant risk of harm, including death. Carefully planned chemotherapy treatments and antibiotic schedules are essential to giving patients the best chance of overcoming their disease. Similarly, the provision of necessary cardiovascular medications must be continuous to preserve their cardiovascular health,' the American Hospital Association said. For the last 10 years, the U.S. has become increasingly reliant on foreign countries for pharmaceuticals or medical equipment because it is less expensive to manufacture overseas. Though tariffs may incentivize the U.S. to begin manufacturing its own drugs, it will not happen overnight and as a result, shortages can occur. But the long-term effects of the tariffs – whether that's shortages or increased drug costs – will not be tangible for several months, Dr. Aaron Kesselheim, a professor of medicine at Harvard Medical School whose research focuses on prescription drugs, told NBC News.
The Independent
08-02-2025
- Business
- The Independent
China makes some of Americans' most common medicines. They won't be spared from Trump's tariffs
President Donald Trump 's broad 10 percent tariff on China could drive up the cost, or cause shortages, of popular generic medicines such as antibiotics or cancer treatment drugs for consumers in the United States, experts have warned. Ordinary painkillers, psychoactive medications, blood thinners, heart medications, antihistamines, antibiotics and diuretics are just some of the essential medications that the U.S. relies on China to manufacture. In 2023, the U.S. spent more than $2.02 billion on these kinds of imports from China alone, according to the U.S. Trade Commission. Trump's additional 10 percent tax on Chinese imports, without an exemption for this, could disrupt the pharmaceutical and medical supply chain, which could lead to shortages or force companies to increase the cost of generic drugs to consumers. In a letter to Trump, the American Hospital Association pleaded with the president to exempt medical equipment and pharmaceuticals from his tariffs, saying the possibility of shortages could put patients 'at significant risk of harm, including death.' 'Tariffs, as well as any reaction of the countries on whom such tariffs are imposed, could reduce the availability of these life-saving medications and supplies in the U.S,' the group wrote. 'For example, U.S. providers import many cancer and cardiovascular medications, immunosuppressives, antibiotics and combination antibiotics from China.' 'Generic manufacturers simply can't absorb new costs,' John Murphy III, the president and CEO of the Association for Accessible Medicines said in a statement. 'Our manufacturers sell at an extremely low price, sometimes at a loss, and are increasingly forced to exit markets where they are underwater. The overall value of all generic sales in the U.S. has gone down by $6.4 billion in five years despite growth in volume and new generic launches. Tariffs would make this much worse,' Murphy said. China supplies the U.S. with approximately 30 percent of its active pharmaceutical ingredients, the raw ingredients found in medicines that make them function, according to the American Hospital Association. China also is one of the U.S.'s main source of medical equipment and devices such as single-use blood pressure cuffs, stethoscope covers, anesthesia instruments and more. Nearly one-third of disposable face masks and almost all plastic gloves come from China. 'For many patients, even a temporary disruption in their access to these needed medications could put them at significant risk of harm, including death. Carefully planned chemotherapy treatments and antibiotic schedules are essential to giving patients the best chance of overcoming their disease. Similarly, the provision of necessary cardiovascular medications must be continuous to preserve their cardiovascular health,' the American Hospital Association said. For the last 10 years, the U.S. has become increasingly reliant on foreign countries for pharmaceuticals or medical equipment because it is less expensive to manufacture overseas. Though tariffs may incentivize the U.S. to begin manufacturing its own drugs, it will not happen overnight and as a result, shortages can occur. But the long-term effects of the tariffs – whether that's shortages or increased drug costs – will not be tangible for several months, Dr. Aaron Kesselheim, a professor of medicine at Harvard Medical School whose research focuses on prescription drugs, told NBC News.
